Literature DB >> 30112329

Profile of non-Hodgkin lymphoma: An Indian perspective.

Ajay Gogia1, Chandan K Das1, Lalit Kumar1, Atul Sharma1, M C Sharma2, Soumya Mallick2.   

Abstract

Entities:  

Year:  2018        PMID: 30112329      PMCID: PMC6069337          DOI: 10.4103/sajc.sajc_60_18

Source DB:  PubMed          Journal:  South Asian J Cancer        ISSN: 2278-330X


× No keyword cloud information.
Dear Editor, Non-Hodgkin lymphoma (NHL) subtype, pattern of presentation as well as patient population, varies with geographical regions. The World Health Organization (WHO) 2016 lymphoma classification clarifies the diagnosis and management of NHL in relation to the stages of lymphomagenesis. It refines the diagnostic criteria to incorporate the expanding genetic/molecular landscape of NHL.[1] In view of comparative data regarding the distribution of NHL subtypes in India is scarce in the literature, we did this retrospective analysis of newly diagnosed patients with NHL treated in a tertiary care center. A total of 390 cases of adult (>18 years) NHL over a period of 27 months (May 1, 2013 and July 31, 2015) were registered in the Department of Medical Oncology at our institute (AIIMS, New Delhi). The individual NHL cases were retrospectively reviewed according to the WHO lymphoma classification 2016 revision, immunophenotypic expression and morphology. B-cell lymphomas formed 347 (89%) whereas T-cell lymphomas formed 43 (11%) of the NHLs. Diffuse large B-cell lymphoma (DLBCL) was the most common subtype which was present in 267 (68.5%) cases. Follicular lymphoma (FL), mantle cell lymphoma (MCL), marginal zone B-cell lymphoma, small lymphocytic lymphoma, and Burkitt's lymphoma amounted to 35 (9%), 20 (5%), 9 (2.3%), 5 (1.3%), and 5 (1.3%) of all NHLs cases, respectively. Among the T-cell lymphomas, peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) was the most common subtype 15 (3.85%), followed by anaplastic large-cell lymphomas, T-cell lymphoblastic lymphoma, NK/T-cell lymphoma, and angioimmunoblastic T-cell lymphoma which accounted for 9 (2.3%), 7 (1.8%), 5 (1.3%), and 2 (0.75%) of all NHL cases, respectively. Details of all NHL are given in Table 1.
Table 1

Non-Hodgkin lymphoma subtypes in adults

Non-Hodgkin lymphoma subtypes in adults The present study of North Indian population shows key differences in the presentation as compared to the developing country and other parts of India. Details of epidemiological studies are summarized in Table 2.
Table 2

Subtype distribution of lymphoma across India and the west (USA)

Subtype distribution of lymphoma across India and the west (USA) Classifying NHL according to B- and T-cell type has therapeutic and prognostic significance. Epidemiology of the Indian subcontinent is marked different from that of the Western literature in view of marked preponderance of high-grade lymphoma especially DLBCL. In this study, 68.5% patients were DLBCL, which is significantly higher as compared to previous reported study from India and the West.[23456] FL and MCL were the second and third most common subtype of B-NHL, and PTCL-NOS is the most common T-cell lymphoma in adult. The younger average age (median 50 years) of our patients is consistent with the pattern seen in most other malignancies in India, due to the effect of a younger population pyramid in our country.[78] The present study of North Indian population shows key differences in the NHL subtypes as compared to the developed world and other parts of India.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  7 in total

1.  Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.

Authors:  K N Naresh; V Srinivas; C S Soman
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

2.  Distribution and clinicopathologic characteristics of non-Hodgkin's lymphoma in India: a study of 935 cases using WHO classification of lymphoid neoplasms (2000).

Authors:  Charandeep S Sahni; Sangeeta B Desai
Journal:  Leuk Lymphoma       Date:  2007-01

3.  Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India.

Authors:  Ramesh B V Nimmagadda; Raghunadharao Digumarti; Reena Nair; Dinesh Bhurani; Vinod Raina; Shyam Aggarwal; Shekhar Patil; Pabitra K Gogoi; Subramanian Sundaram; Chanchal Goswami; Shashikant Apte; Srinivas Chakravarthy; Anand Pathak
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10

4.  Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5115 cases using the World Health Organization 2008 classification and comparison with world literature.

Authors:  Neeraj Arora; Marie Therese Manipadam; Sheila Nair
Journal:  Leuk Lymphoma       Date:  2012-10-01

Review 5.  Epidemiology of Non-Hodgkin's Lymphoma in India.

Authors:  Reena Nair; Neeraj Arora; Mohandas K Mallath
Journal:  Oncology       Date:  2016-07-28       Impact factor: 2.935

6.  Follicular lymphoma: an Institutional Analysis

Authors:  Ajay Gogia; Vinod Raina; Lalit Kumar; Atul Sharma; Mehar Chand Sharma; Saumya Ranjan Mallick
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

7.  Mantle Cell Lymphoma: A North Indian Tertiary Care Centrezzm321990Experience

Authors:  Chandan Krushna Das; Ajay Gogia; Lalit Kumar; Atul Sharma; Mehar Chand Sharma; Saumya Ranjan Mallick
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01
  7 in total
  5 in total

1.  Prognostic Role of Interim 18-Fluorodeoxyglucose-PET in Diffuse Large B Cell Lymphoma: Experience from a Tertiary Care Centre in North India.

Authors:  Sujeet Kumar; Anshul Gupta; Manish Ora; Khaliqur Rahman; Reena Choudhary; Soniya Nityanand
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-04       Impact factor: 0.900

Review 2.  Current trends in diagnosis and management of follicular lymphoma.

Authors:  Gopila Gupta; Vikas Garg; Saumyaranjan Mallick; Ajay Gogia
Journal:  Am J Blood Res       Date:  2022-08-15

3.  Clinico-Pathologic Profile and Treatment Outcomes of Patients with Diffuse Large B Cell Lymphoma Based on Cell of Origin Classification.

Authors:  Sohan Singh Mandloi; Divya Bala Thumaty; Yadav Nisha; Smita Kayal; Prasanth Ganesan; Sajini Elizabeth Jacob; Debdatta Basu; Biswajit Dubashi
Journal:  Indian J Hematol Blood Transfus       Date:  2020-07-27       Impact factor: 0.900

4.  Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India.

Authors:  Ajay Gogia; Sukesh Nair; Shalabh Arora; Lalit Kumar; Atul Sharma; Ritu Gupta; Ahitagni Biswas; Saumyaranjan Mallick
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

5.  Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in India.

Authors:  Sudhir Kumar; Atul Sharma; Raja Pramanik; Neha Pathak; Ajay Gogia; Akash Kumar; Smita Kayal; Vinod Sharma; Ranjit Kumar Sahoo; Sanjay Thulkar; M C Sharma; Ritu Gupta; Soumya Mallick; Mercy Thomas; Vinod Raina
Journal:  JCO Glob Oncol       Date:  2022-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.